Benzinga | Nov 9, 2021 11:13AM EST

Cytek Biosciences Q3 EPS $0.02, Inline, Sales $34.40M Beat $33.39M Estimate

Cytek Biosciences (NASDAQ:CTKB) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. The company reported quarterly sales of $34.40 million which beat the analyst consensus estimate of $33.39 million by 3.02 percent.